Cargando…
Exploring the New Horizon of AdipoQ in Obesity-Related Alzheimer’s Dementia
Alzheimer’s disease (AD) is the most common form of dementia, which causes abnormalities in learning, thinking, memory, as well as behavior. Generally, symptoms of AD develop gradually and aggravate over time, and consequently severely interfere with daily activities. Furthermore, obesity is one of...
Autores principales: | Uddin, Md. Sahab, Rahman, Md. Motiar, Sufian, Mohammad Abu, Jeandet, Philippe, Ashraf, Ghulam Md., Bin-Jumah, May N., Mousa, Shaker A., Abdel-Daim, Mohamed M., Akhtar, Muhammad Furqan, Saleem, Ammara, Amran, Md. Shah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873563/ https://www.ncbi.nlm.nih.gov/pubmed/33584324 http://dx.doi.org/10.3389/fphys.2020.567678 |
Ejemplares similares
-
Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
por: Uddin, Md. Sahab, et al.
Publicado: (2020) -
Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020) -
Combination Drug Therapy for the Management of Alzheimer’s Disease
por: Kabir, Md. Tanvir, et al.
Publicado: (2020) -
Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020) -
Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020)